One in Five Paxlovid Users Experience COVID Rebound Infections
A new study published earlier this month suggests that people who took Pfizer’s Paxlovid (nirmatrelvir-ritonavir)—an antiviral drug treatment for COVID-19—are much more likely to experience reinfection than those who did not take the drug. The study, published in the Annals of Internal Medicine, reported that one in five people who take Paxlovid could experience rebound […]
U.S. Taxpayer Funded Initiative Trains Dentists to Push HPV Vaccine
In recent years, government health agencies, cancer societies, as well as the American Dental Association (ADA), have attempted to recruit dentists to advocate for patients to get the human papillomavirus (HPV) vaccine to prevent oral cancers. An HPV Vaccine Roundtable initiative, funded largely by the U.S. Centers for Disease Control and Prevention (CDC), advises dentists […]
Understanding the 500 Percent Price Increase of Pfizer’s COVID Vaccine
During a 2021 earnings call with stockholders, Pfizer Chief Financial Officer Frank D’Amelio discussed how the company was using “pandemic pricing” to charge $19.50 per COVID-19 vaccine dose, a product it expected to make $15 billion on in 2021. “[There’s] significant opportunity for those margins to improve once we get beyond the pandemic environment that […]
Fatty Liver Disease Rates Increasing in American Children
Prior to the turn of the 21st century, only a handful of cases of pediatric fatty liver disease were documented in medical literature. Today the non-alcoholic liver disease affects millions of children and has more than doubled according to data from 2017-2021. Fatty liver disease is now estimated to be about as common as asthma […]
Blood Pressure Drug Recalled After Oxycodone Found on Production Line
Drug manufacturer KVK-Tech, Inc. has issued a voluntary recall of blood pressure drug betaxolol after oxycodone was discovered on the production line. The recall notice, published Sept. 29, 2023 by the U.S. Food and Drug Administration (FDA), says the precautionary measure is being taken following the discovery of a single 5 mg Oxycodone Hydrogen Chloride […]
FDA Panel Statements Prompt Pharmacies to Pull Popular Nasal Decongestants from Pharmacy Shelves
Conventional over-the-counter cold meds promise cold symptom relief right on the front of their packaging, but U.S. Food and Drug Administration (FDA) advisors have stated that an active ingredient in many popular cold medicines is not effective in relieving congestion when taken orally. An advisory panel for the FDA unanimously concluded recently that phenylephrine, a […]
